BetterLife Pharma (BETRF) Net Income (2016 - 2026)
BetterLife Pharma (BETRF) posted quarterly Net Income of -$446911.4 for Q2 2026, down 207.15% year-over-year from $417090.5 in Q2 2025, and down 21.7% quarter-over-quarter from -$367231.0 in Q3 2025.
BetterLife Pharma (BETRF) Net Income (2016 - 2026) Analysis & Trends
BetterLife Pharma's Net Income history runs 11 years deep, the most recent figure standing at -$446911.4 for Q2 2026.
- In Q2 2026, Net Income fell 207.15% year-over-year to -$446911.4; the TTM figure through Apr 2026 stood at -$959645.2 (down 31.01% YoY), while the FY2026 annual figure was -$1.1 million, up 56.56% from the prior year.
- Net Income for Q2 2026 stood at -$446911.4, down from -$367231.0 in the prior quarter.
- The five-year high for Net Income was $470693.9 in Q4 2024, with the low at -$3.5 million in Q4 2022.
- The 5-year median for Net Income is -$741047.8 (2023), against an average of -$1.1 million.
- The sharpest annual moves came in 2024 and 2026: Net Income soared 398.61% in 2024, then slumped 207.15% in 2026.
- BetterLife Pharma's Net Income stood at -$3.5 million in 2022, then surged by 95.53% to -$157629.0 in 2023, then jumped by 398.61% to $470693.9 in 2024, then plunged by 178.02% to -$367231.0 in 2025, then decreased by 21.7% to -$446911.4 in 2026.
- Business Quant data shows BETRF's Net Income at -$446911.4 in Q2 2026, -$367231.0 in Q3 2025, and -$145502.8 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - | -446,911.44 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -446,911.44 |
| Jul 31, 2025 | -367,231.02 |
| Apr 30, 2025 | -145,502.79 |
| Oct 31, 2024 | 470,693.94 |
| Jul 31, 2024 | -1.06 Mn |
| Apr 30, 2024 | -1.51 Mn |
| Oct 31, 2023 | -157,628.99 |
| Jul 31, 2023 | -769,896.81 |
| Apr 30, 2023 | -712,198.78 |
| Jan 31, 2023 | -429,833.05 |
| Oct 31, 2022 | -3.52 Mn |
| Jul 31, 2022 | -874,794.99 |
| Apr 30, 2022 | -2.36 Mn |
| Jan 31, 2022 | -3.11 Mn |
| Oct 31, 2021 | -1.76 Mn |
| Jul 31, 2021 | -2.91 Mn |
| Apr 30, 2021 | -1.94 Mn |
| Jan 31, 2021 | -21.38 Mn |
| Oct 31, 2020 | -5.56 Mn |
| Jul 31, 2020 | -1.14 Mn |